JP2006515560A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006515560A5 JP2006515560A5 JP2004512682A JP2004512682A JP2006515560A5 JP 2006515560 A5 JP2006515560 A5 JP 2006515560A5 JP 2004512682 A JP2004512682 A JP 2004512682A JP 2004512682 A JP2004512682 A JP 2004512682A JP 2006515560 A5 JP2006515560 A5 JP 2006515560A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- unbranched
- branched
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38946102P | 2002-06-17 | 2002-06-17 | |
| US10/463,009 US7037936B2 (en) | 2002-06-17 | 2003-06-16 | Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
| PCT/US2003/018905 WO2003105774A2 (en) | 2002-06-17 | 2003-06-17 | Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006515560A JP2006515560A (ja) | 2006-06-01 |
| JP2006515560A5 true JP2006515560A5 (enExample) | 2006-08-03 |
Family
ID=29740147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004512682A Pending JP2006515560A (ja) | 2002-06-17 | 2003-06-17 | 癌の治療に有用な化合物、その組成物、およびそれを用いる方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7037936B2 (enExample) |
| EP (1) | EP1551388A4 (enExample) |
| JP (1) | JP2006515560A (enExample) |
| CN (1) | CN1674888A (enExample) |
| AU (1) | AU2003243587B2 (enExample) |
| CA (1) | CA2488891A1 (enExample) |
| IL (1) | IL165839A0 (enExample) |
| MX (1) | MXPA04012675A (enExample) |
| NZ (1) | NZ537653A (enExample) |
| WO (1) | WO2003105774A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050100529A1 (en) * | 2003-11-06 | 2005-05-12 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders |
| US8175808B2 (en) * | 2005-04-01 | 2012-05-08 | Sloan Kettering Institute For Cancer Research | Method for determining disease treatment duration |
| AU2006320374B2 (en) | 2005-12-02 | 2012-08-30 | Isis Pharmaceuticals, Inc. | Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents |
| WO2010030704A2 (en) | 2008-09-10 | 2010-03-18 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2010030690A1 (en) | 2008-09-10 | 2010-03-18 | Isis Pharmaceuticals, Inc. | Antibacterial 4,6-substituted 6', 6" and 1 modified aminoglycoside analogs |
| WO2010042850A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2010042851A1 (en) | 2008-10-09 | 2010-04-15 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| JP2013507391A (ja) | 2009-10-09 | 2013-03-04 | アカオジェン インコーポレイテッド | 抗ウイルスアミノグリコシド類似体 |
| WO2012002527A1 (ja) * | 2010-07-02 | 2012-01-05 | あすか製薬株式会社 | 複素環化合物及びｐ２７Ｋｉｐ１分解阻害剤 |
| US8318685B2 (en) | 2010-11-17 | 2012-11-27 | Achaogen, Inc. | Antibacterial aminoglycoside analogs |
| WO2012075232A1 (en) * | 2010-12-04 | 2012-06-07 | Trevena, Inc. | Opioid receptor ligands and methods of using and making the same |
| JP2024523237A (ja) | 2021-06-18 | 2024-06-28 | ホンジーン バイオテック コーポレイション | 官能化されたｎ－アセチルガラクトサミンヌクレオシド |
| JP2024532271A (ja) | 2021-08-30 | 2024-09-05 | ホンジーン バイオテック コーポレイション | 官能化ｎ－アセチルガラクトサミンアナログ |
| US11993626B2 (en) | 2021-12-15 | 2024-05-28 | Hongene Biotech Corporation | Functionalized N-acetylgalactosamine analogs |
| US12116382B2 (en) | 2022-11-28 | 2024-10-15 | Hongene Biotech Corporation | Functionalized N-acetylgalactosamine analogs |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3328249A (en) * | 1965-06-21 | 1967-06-27 | Sterling Drug Inc | Process for counteracting depressive states |
| US3485873A (en) * | 1966-12-21 | 1969-12-23 | Sterling Drug Inc | N-benzyl-n-methyl-omega-phenyl-omega-cycloalkyl-lower-alkylamines |
| GB9201755D0 (en) | 1992-01-28 | 1992-03-11 | British Bio Technology | Compounds |
| CA2341064A1 (en) | 1998-08-28 | 2000-03-09 | New York University | Novel ubiquitin ligases as therapeutic targets |
| DE69943222D1 (de) | 1998-12-10 | 2011-04-07 | Signal Pharm Llc | Menschliche ubiqutin ligase e3. verwendung für die modulation von nf-kappa b |
| US20010044445A1 (en) * | 1999-04-08 | 2001-11-22 | Bamaung Nwe Y. | Azole inhibitors of cytokine production |
| JP4121854B2 (ja) | 2001-01-05 | 2008-07-23 | ニューヨーク・ユニバーシティ | 増殖性および分化性疾患の治療に有用な化合物の同定方法 |
| CA2486933A1 (en) * | 2002-05-31 | 2003-12-11 | Yamanouchi Pharmaceutical Co., Ltd. | Tetrahydropyran derivative |
-
2003
- 2003-06-16 US US10/463,009 patent/US7037936B2/en not_active Expired - Fee Related
- 2003-06-17 MX MXPA04012675A patent/MXPA04012675A/es active IP Right Grant
- 2003-06-17 CN CNA038193191A patent/CN1674888A/zh active Pending
- 2003-06-17 WO PCT/US2003/018905 patent/WO2003105774A2/en not_active Ceased
- 2003-06-17 CA CA002488891A patent/CA2488891A1/en not_active Abandoned
- 2003-06-17 NZ NZ537653A patent/NZ537653A/en unknown
- 2003-06-17 EP EP03760389A patent/EP1551388A4/en not_active Withdrawn
- 2003-06-17 AU AU2003243587A patent/AU2003243587B2/en not_active Ceased
- 2003-06-17 IL IL16583903A patent/IL165839A0/xx unknown
- 2003-06-17 JP JP2004512682A patent/JP2006515560A/ja active Pending
-
2006
- 2006-02-17 US US11/357,774 patent/US20060142352A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006515560A5 (enExample) | ||
| US9321772B2 (en) | Substituted pyrazolo[3,4-D]pyrimidines and uses thereof | |
| Govender et al. | Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity? | |
| JP2824917B2 (ja) | 抗腫瘍剤 | |
| WO2008123755A1 (en) | A pharmaceutical compositions containing lactam type pyridine derivatives as an effective ingredient for the prevention and treatment of ischemia | |
| JP2006501201A5 (enExample) | ||
| Van Es et al. | The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres | |
| TWI862414B (zh) | 難治性癌症之預防或治療用之醫藥組合物 | |
| JPWO2020037091A5 (enExample) | ||
| PT1105136E (pt) | Método para tratar doenças oculares neovasculares | |
| EP0794786B1 (en) | The use of inositoltrisphosphate for the preparing of medicaments | |
| US20110269784A1 (en) | Use of tetrahydropyrimidines | |
| Duff et al. | High-dose nitrogen mustard therapy with intermittent aortic occlusion | |
| Sutanto-Ward et al. | Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing | |
| WO2020177290A1 (zh) | 一种药物组合物及其制备方法和用途 | |
| CN210331361U (zh) | 多孔缓释化疗植入体 | |
| CN103127510B (zh) | 含有肝细胞生长因子受体抑制剂和Bcl-2抑制剂的药物组合物及其应用 | |
| CN113730575A (zh) | 一种治疗眼部恶性肿瘤的非氧自由基损伤增强光热治疗体系的靶向药物及其制备方法与应用 | |
| CN107625781B (zh) | miRNA抑制子在制备防治心肌梗死药物中的应用 | |
| ES2932270B2 (es) | Compuesto de rutenio (iii) y 2,2'-biimidazol (runat-bi) y su uso terapeutico | |
| WO2013024312A1 (en) | A pharmaceutical composition for the treatment of stem cells | |
| HRP20200897T1 (hr) | Parenteralna formulacija esmolola | |
| Iturrioz-Rodríguez et al. | Establishment of an orthotopic glioblastoma mouse model for preclinical studies | |
| Rioja et al. | Anesthetic management of an off-pump open-heart surgery in a dog | |
| JP2015520142A5 (enExample) |